Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

SomnoMed Limited

Investor presentation - SomnoMed Limited

ASX:SOM

SomnoMed Limited

Health

SomnoMed Limited (SOM) provides diagnostic and treatment solutions for Sleep-related Breathing Disorders including obstructive sleep apnea, snoring and bruxism. SomnoDent provides medical oral appliance therapy for over 300,000 patients in 27 countries. Former Names --

Market Cap

$154.76m

Price at Close

$1.87

4w avg. Volume

30.56k

4w avg. Turnover

$63.77k

Announcements
announcementt+2 movementdate
  • Change in substantial holding

    Shareholder Details

  • +3.26%

    04 Jan 2021

+3.26%

04 Jan 2021
  • Change of Director's Interest Notice

    Shareholder Details

  • +1.39%

    01 Dec 2020

+1.39%

01 Dec 2020
  • Initial Director's Interest Notice

    Shareholder Details

  • 0.00%

    27 Nov 2020

0.00%

27 Nov 2020
  • Results of Meeting

    Notice Of Meeting

  • -5.50%

    26 Nov 2020

-5.50%

26 Nov 2020
  • AGM Presentation and addresses

    Periodic Reports · Market sensitive

  • -0.46%

    25 Nov 2020

-0.46%

25 Nov 2020
  • SomnoMed Board appointment

    Company Administration

  • +10.58%

    08 Nov 2020

+10.58%

08 Nov 2020
  • Appendix 4C - quarterly

    Commitments test entity quarterly reports · Market sensitive

  • -1.35%

    20 Oct 2020

-1.35%

20 Oct 2020
  • Improved quarterly performance

    Periodic Reports · Market sensitive

  • -1.35%

    20 Oct 2020

-1.35%

20 Oct 2020
  • Annual General Meeting Proxy Form

    Notice Of Meeting

  • 0.00%

    16 Oct 2020

0.00%

16 Oct 2020
  • Notice of Annual General Meeting

    Notice Of Meeting

  • 0.00%

    16 Oct 2020

0.00%

16 Oct 2020
Market Data

Current Price

$1.87

52WK HIGH

$3.44

52WK LOW

$0.9

1YR RETURN

-37.67%

1YR RETURN VS. SECTOR

-77.93%

90 DAY RETURN

-8.78%

ASX RANK

719

/2,048

SECTOR RANK

64

/168

SHARES OUTSTANDING

82.76m
ASX:SOM

SomnoMed Limited

Health

SomnoMed Limited (SOM) provides diagnostic and treatment solutions for Sleep-related Breathing Disorders including obstructive sleep apnea, snoring and bruxism. SomnoDent provides medical oral appliance therapy for over 300,000 patients in 27 countries. Former Names --

Market Cap

$154.76m

Price at Close

$1.87

4w avg. Volume

30.56k

4w avg. Turnover

$63.77k

ASX:SOM is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.